Terms: = Germ cell tumor AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Prognosis
93 results:
1. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
2. VEGF/vegfr axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
[TBL] [Abstract] [Full Text] [Related]
3. MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over vegfr/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis.
Tao J; Cui J; Xu Y; Fan Y; Hong G; Zhou Q; Wang G; Li L; Han Y; Xu C; Wang W; Cai S; Zhang X
Aging (Albany NY); 2024 Jan; 16(3):2090-2122. PubMed ID: 38301040
[No Abstract] [Full Text] [Related]
4. Network pharmacology-based strategy to investigate the effect and mechanism of α-solanine against glioma.
Wang C; Liu X; Guo S
BMC Complement Med Ther; 2023 Oct; 23(1):371. PubMed ID: 37865727
[TBL] [Abstract] [Full Text] [Related]
5. Gestational choriocarcinoma.
Bogani G; Ray-Coquard I; Mutch D; Vergote I; Ramirez PT; Prat J; Concin N; Ngoi NYL; Coleman RL; Enomoto T; Takehara K; Denys H; Lorusso D; Takano M; Sagae S; Wimberger P; Segev Y; Kim SI; Kim JW; Herrera F; Mariani A; Brooks RA; Tan D; Paolini B; Chiappa V; Longo M; Raspagliesi F; Benedetti Panici P; Di Donato V; Caruso G; Colombo N; Pignata S; Zannoni G; Scambia G; Monk BJ
Int J Gynecol Cancer; 2023 Oct; 33(10):1504-1514. PubMed ID: 37758451
[TBL] [Abstract] [Full Text] [Related]
6. PDGFRA, KIT, and kdr Gene Amplification in Glioblastoma: Heterogeneity and Clinical Significance.
Carlotto BS; Trevisan P; Provenzi VO; Soares FP; Rosa RFM; Varella-Garcia M; Zen PRG
Neuromolecular Med; 2023 Sep; 25(3):441-450. PubMed ID: 37610648
[TBL] [Abstract] [Full Text] [Related]
7. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
[TBL] [Abstract] [Full Text] [Related]
8. Radiomics-based survival risk stratification of glioblastoma is associated with different genome alteration.
Xu PF; Li C; Chen YS; Li DP; Xi SY; Chen FR; Li X; Chen ZP
Comput Biol Med; 2023 Jun; 159():106878. PubMed ID: 37060774
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA SPRY4-IT1 facilitates cell proliferation and angiogenesis of glioma via the miR-101-3p/EZH2/VEGFA signaling axis.
Wang J; Chen Y; Wang Q; Xu H; Jiang Q; Wang M; Li S; Chen Y; Wu C; Yu P; Xiao Z; Chen W; Lan Q
Cancer Med; 2023 Mar; 12(6):7309-7326. PubMed ID: 36479622
[TBL] [Abstract] [Full Text] [Related]
10. Genetic Alterations of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis.
Pala L; Bagnardi V; Tettamanzi F; Barberis M; Mazzarol G; Casali C; De Pas T; Pennacchioli E; Coppola S; Baldini F; Cocorocchio E; Ferrucci P; Patane' D; Saponara M; Queirolo P; Conforti F
Mol Diagn Ther; 2023 Jan; 27(1):5-13. PubMed ID: 36401787
[TBL] [Abstract] [Full Text] [Related]
11. ARL13B promotes angiogenesis and glioma growth by activating VEGFA-vegfr2 signaling.
Chen L; Xie X; Wang T; Xu L; Zhai Z; Wu H; Deng L; Lu Q; Chen Z; Yang X; Lu H; Chen YG; Luo S
Neuro Oncol; 2023 May; 25(5):871-885. PubMed ID: 36322624
[TBL] [Abstract] [Full Text] [Related]
12. Maximum Value on Arterial Phase Computed Tomography Predicts prognosis and Treatment Efficacy of Sunitinib for Pancreatic Neuroendocrine Tumours.
Chen H; Li Z; Hu Y; Xu X; Ye Z; Lou X; Zhang W; Gao H; Qin Y; Zhang Y; Chen X; Chen J; Tang W; Yu X; Ji S
Ann Surg Oncol; 2023 May; 30(5):2988-2998. PubMed ID: 36310316
[TBL] [Abstract] [Full Text] [Related]
13. The Overexpression of SLC25A13 Predicts Poor prognosis and Is Correlated with Immune cell Infiltration in Patients with Skin Cutaneous Melanoma.
Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
[TBL] [Abstract] [Full Text] [Related]
14. Anti-vegfr2 monoclonal antibody(MSB0254) inhibits angiogenesis and tumor growth by blocking the signaling pathway mediated by vegfr2 in glioblastoma.
Chen S; Li X; Wang H; Chen G; Zhou Y
Biochem Biophys Res Commun; 2022 May; 604():158-164. PubMed ID: 35305420
[TBL] [Abstract] [Full Text] [Related]
15. Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/vegfr-2 interaction.
Landras A; Reger de Moura C; Villoutreix BO; Battistella M; Sadoux A; Dumaz N; Menashi S; Fernández-Recio J; Lebbé C; Mourah S
Oncogene; 2022 Apr; 41(15):2254-2264. PubMed ID: 35217792
[TBL] [Abstract] [Full Text] [Related]
16. Combining apatinib and temozolomide for brainstem glioblastoma: a case report and review of literature.
Zhu Y; Zhao L; Xu Y; Zhan W; Sun X; Xu X
Ann Palliat Med; 2022 Jan; 11(1):394-400. PubMed ID: 35144430
[TBL] [Abstract] [Full Text] [Related]
17. Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an immunomodulatory microenvironment in glioblastoma.
Yang K; Shi Y; Luo M; Mao M; Zhang X; Chen C; Liu Y; He Z; Liu Q; Wang W; Luo C; Yin W; Wang C; Niu Q; Zeng H; Bian XW; Ping YF
Oncoimmunology; 2022; 11(1):2030020. PubMed ID: 35096487
[TBL] [Abstract] [Full Text] [Related]
18. Functional In Vitro Assessment of VEGFA/NOTCH2 Signaling Pathway and pRB Proteasomal Degradation and the Clinical Relevance of Mucolipin TRPML2 Overexpression in Glioblastoma Patients.
Santoni G; Amantini C; Nabissi M; Arcella A; Maggi F; Santoni M; Morelli MB
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054871
[TBL] [Abstract] [Full Text] [Related]
19. Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma.
Dono A; Zhu P; Holmes E; Takayasu T; Zhu JJ; Blanco AI; Hsu S; Bhattacharjee MB; Ballester LY; Kim DH; Esquenazi Y; Tandon N
J Neurooncol; 2022 Jan; 156(2):353-363. PubMed ID: 34997451
[TBL] [Abstract] [Full Text] [Related]
20. Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma.
Zhou Q; Yan X; Zhu H; Xin Z; Zhao J; Shen W; Yin W; Guo Y; Xu H; Zhao M; Liu W; Jiang X; Ren C
Theranostics; 2021; 11(20):9775-9790. PubMed ID: 34815785
[No Abstract] [Full Text] [Related]
[Next]